Unlike B16/F10 melanoma cells, we found no evidence of interferon pathway activation in MC38 cells treated with LSD1 chemical inhibitors such as GSK-LSD1, which is a tool compound of GSK2879552, and ORY1001 (Fig. 1e). This evidence concerns the gene KDM1A and melanoma.